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Case presentation
This 26-year-old woman was in good health until 6 years ago
when she developed membranoproliferative glomerulonephritis.
After 3 years of progressive, functional renal deterioration, the
patient began chronic hemodialysis. After 14 months of hemo-
dialysis, accompanied by depression and poorly controlled hy-
pertension, the patient was encouraged to accept a 4/4 HLA-
identical graft from her 21-year-old brother. Two weeks follow-
ing transplantation, she had a severe rejection episode, which
was treated with 7 grams of methylprednisolone; hemodialysis
was required for 2 weeks but her renal function improved sub-
sequently. Two months after transplantation, the serum creati-
nine concentration was 1.2 mg/dl. Renal function has remained
stable for the last 18 months; the most recent value for serum
creatinine was 0.9 mg/dl. Her therapeutic regimen included:
prednisone, 30 mg every other day; azathioprine, 100 mg/day;
and antihypertensive medications. Despite the restoration of
normal renal function, the patient's psychiatric stance did not
improve following transplantation.
The patient was a nurse's aide in a nursing home prior to the
onset of her renal disease. She is the oldest of three children; her
two brothers are 18 and 21 years old. The patient's parents sepa-
rated when she was 7 years old. After the separation, she lived
with her mother with whom she had a hostile and dependent rela-
tionship. The mother remarried but was divorced 6 years ago.
The patient's family life was chaotic and unstable and included
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many episodes of alcohol-associated physical abuse by her fa-
ther. During the patient's 14 months of dialysis, she experienced
severe depression, which was manifest as withdrawal, difficulty
sleeping at night, and an inability to communicate with the nurs-
ing and medical staff. She would frequently sleep during the en-
tire dialysis session, thereby avoiding all contact. The patient
had some suicidal thoughts while undergoing dialysis but denied
ever attempting suicide. Her depression was treated with ami-
triptyline, and her energy level and personal care improved. Fol-
lowing "successful" transplantation, the patient again became
depressed and addicted to narcotics, requiring up to 12 tablets of
Percodan® or Percocet® per day. During a live and one-half
month period after transplantation, she took a minimum of 1345
Percodan® tablets.
The patient was admitted to the psychiatric unit approximately
8 months following transplantation for evaluation of depression
and drug abuse. Narcotic withdrawal was not successful and she
was discharged receiving methadone instead of Percodan®. She
stated then that she had been depressed 'since the transplant."
It became apparent that the patient had suffered several losses
over the preceding years:first, she had become very attached to
the dialysis unit and lost that relationship after successful trans-
plantation; second, the dialysis social worker with whom she had
worked quite closely left; third, she had a severe rejection epi-
sode following kidney transplantation and was afraid of losing
the kidney; fourth, she was engaged to an older, divorced man
prior to the onset of her renal failure, and the restoration of nor-
mal renal function allowed her to consider marriage, thus threaten-
ing her with separation from her mother. Finally, the patient was
quite disappointed that the anticipated dramatic change in her life
did not occur after successful treatment of her kidney failure.
In summary, the patient is a young woman with chronic renal
failure who, following HLA-identical kidney transplantation,
achieved restoration of normal renal function but has not
achieved an independent mode of living. Severe depression, an-
tedating her kidney transplant has persisted, and drug depend-
ency has become a major problem.
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Discussion
Dg. SAMUEL H. BASCH (Associate Clinical Pro-
fessor of Psychiatry, Mount Sinai School of Medi-
cine, and Consultant Robert Wood Johnson, Jr. Re-
nal Treatment Center, Mt. Sinai Hospital, New York,
New York): It is appropriate at this time in the
growth and progress in the field of nephrology that
we accord proper attention to the psychologic state
and general welfare of the renal patient. As the
kidney patient's life expectancy is artifically ex-
tended by medical technology, sophisticated sur-
gery, and space-age pharmacology, quality-of-life
issues become more prominent. Physicians are
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involved in more complex and sometimes unsettling
ways, which are demonstrated by the types of
problems that emerged in caring for this patient
and by the treatment choices that confronted the
medical staff. This patient also raises several issues
relevant to modern forms of renal care and their
psychologic impact on the patient.
Increasingly, medical attention has been drawn to
the profound psychologic effects of end-stage renal
disease and its treatments on the total functioning of
the patient [1]. In Hamlet, Shakespeare captured
the essence of this predicament when King
Claudius stated.
Diseases desperate grown
By desperate appliance are relieved,
Or not at all. (IV, iii, 9—11)
Our patient certainly was so struck by both the
disease and its treatment.
Renal disease early in life
The patient presented was first stricken with
membranoproliferative glomerulonephritis when
she was 20, barely out of her teens. Her age is rele-
vant, because renal disease cannot only stunt phys-
ical development but also can cause retardation or
regression of emotional growth [2]. Our patient,
perhaps immature despite her age, most likely expe-
rienced a suspension of her personality develop-
ment with the onset of her renal disease.
Renal disease frequently occurs early in life and,
when it does, it often has subsequent life-long psy-
chologic and physical consequences. Stunted
growth, anomalies accompanying certain renal dis-
orders, and physical changes from kidney disease
exaggerate the patient's sense of being different, if
not odd, and lead to isolation. The young person
might feel like an invalid or misfit and tend to with-
draw voluntarily. Medical visits, episodes of illness,
and hospitalizations interfere with the patient's
schedule and activities. Lack of social activities and
exposure deprive the young individual of the inter-
action and experience necessary for emotional
growth and development. When the treatment itself
becomes central, as in hemodialysis or trans-
plantation, it can replace other dimensions of life
and virtually become life itself. Kidney disease im-
posed itself on this patient; the disorder and its ther-
apy absorbed the patient's resources, time, and en-
ergy while the rest of her life stood still. Her world
became a renal worEd at age 20.
Personality and diagnosis
Our patient's history describes her in various
contexts as hostile and dependent, depressed and
withdrawn, noncommunicative, and having a chaot-
ic and unstable background. A battery of psycho-
logic examinations, although not reported, was in-
dicated and would have provided an additional
basis for information and understanding. These ex-
aminations can uncover hidden psychopathologic
entities not readily apparent clinically. These tests
can sometimes reveal conditions such as depression
or anxiety. Also, the tests can diagnose the organic
mental syndrome and a range of psychoses and
neuroses [3].
The psychiatric differential diagnosis is important
here. This patient's history does not indicate schiz-
oid, borderline, or schizophrenic diagnoses, all of
which would have to be investigated in a patient
with this history and clinical course. Psychologic
evaluation prior to therapy is essential because the
psychologic outcome of the treatment can be under-
stood only in terms of the individual's psycho-
pathologic conditions. Just as the patient's pre-
operative physical status influences the outcome of
surgery, so does the psychologic matrix affect the
psychiatric outcome and life adjustment of the pa-
tient. The depressed or schizoid individual stricken
with renal disease cannot readily emerge from dial-
ysis or transplantation with good mental health.
The history described unfolds the story of a
young woman who has had psychologic distur-
bances since childhood. However, the case material
is not sufficient to provide evidence of a severe,
specific underlying psychiatric disorder. The con-
sideration of whether any deep psychopathology
does exist, however, leads to an examination of an
area of recent inquiry that also links psychiatry and
nephrology.
Schizophrenia and dialysis
In l%0, Feer et al. reported improvement in
three of five patients with schizophrenia treated
with dialysis [4]. The observation lay dormant until
recently when psychiatrist Wagemaker and ne-
phrologist Cade described dialysis as an effective
treatment in a small number of patients with schizo-
phrenia [5]. Palmour, a biochemist at Berkeley,
studied Wagemaker's patients and reported a hun-
dredfold higher concentration of /3-Leu5-endorphin
in fluid of the first dialysate than in the fluid of the
16th dialysate [5]. This finding suggested that the
metabolic stores of the aberrant peptide gradually
were being diminished by the treatment. Yet this
peptide, found to be very active when injected into
animals, has not been shown to react similarly in
humans. Information that could offer a different ex-
planation as to how hemodialysis could relieve
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schizophrenia was offered by twin articles in a re-
cent issue of Lan cei', which reported a virus-like
agent in the cerebrospinal fluid of more than one-
third of several dozen schizophrenic patients stud-
ied [6, 71.
The notion that an agent causative for schizo-
phrenia is removed by hemodialysis remains moot.
Patients with normal kidney function have been
studied, and dialysis obviously adds only slightly to
the glomerular filtration capacity in these patients;
the unknown agent therefore would have to be fil-
tered in the glomerulus and resorbed by the tubule.
Since the artificial kidney does not resorb, this
could explain eliminating the agent during dialysis
[8]. The clearance of middle-molecule polypeptides
is lower for the dialysis machine than for the kidney
itself [9]. /3-Leu5-endorphin, a middle-molecule
polypeptide, thus would be better removed by the
normal kidney than by a dialyzing machine. Fur-
thermore, protein and protein-bound agents are not
removed by normal kidney function or through dial-
ysis. The alleged schizophrenia-inducing agent
therefore would have to be a small, non-protein-
bound molecule that in a normal kidney is resorbed
completely by the tubule [8]. However, research on
this topic to date has not provided convincing data
118]. No reports of controlled and double-blind sham
dialysis studies utilizing ranges of surface area and
membrane permeability have been published.
He,nodialvsis versus transplantation
Let us now return to our patient. Despite the lack
of evidence supporting the thesis that dialysis can
cure—or at best control—psychologic problems,
the case report suggests that the psychiatric symp-
toms of this patient might have been less prominent
during hemodialysis than after transplantation. This
possibility raises the issue of treatment choice,
namely, whether hemodialysis, although not cura-
tive, might be psychologically more salutary than is
renal transplantation in certain individuals. With
the advantage of retrospection, we recognize that
this young woman made an adjustment, albeit mar-
ginal, on hemodialysis.
The decision for renal transplantation is based on
a multitude of factors, including the bias of the renal
unit toward dialysis or transplantation; the empha-
sis, experience, and expertise of the medical and
surgical staff in dialysis and transplantation; the
general medical condition of the patient; and the
staff's quest for improvement of the patient's phys-
ical state. When the decision to transplant has been
made, the staff often has a unified approach in pre-
senting the recommendation to the patient. Most
patients, because they trust the dialysis staff and
are not equipped with the in-depth knowledge that
the medical personnel hold, accept the recommend-
ed treatment. These patients even might concur
with the recommendation because they feel vulner-
able, dependent, are afraid to refuse, or wish to
please the staff. If the patient accepts the recom-
mended transplant, as did the patient presented
today, and if the medical or psychologic outcome is
questionable, a pall might be cast on the original de-
cision, with the medical staff experiencing uncom-
fortable feelings of doubt, regret, or guilt. Accord-
ingly, uncertainties regarding treatment choice pro-
duce anxieties among the staff and can affect future
medical decisions. Although these factors might or
might not have been germane to the care of this pa-
tient, we should take them into account.
Depression, loss, and self-destructive behavior
Almost every individual sustains a reactive de-
pression when faced with a profound illness like
renal failure and its treatment. This depression is
manifest by a lowering of spirits and a reduction in
self-esteem. Diagnosing depression in the renal pa-
tient is difficult: the usual physiologic concomitants
of depression such as changes in eating, sleeping,
and bowel habits are difficult to evaluate in light of
the patient's complex metabolic situation [10]. In-
somnia, as in our patient, can lead to depression but
also can be a manifestation of depression. The re-
versal of diurnal patterns and other sleep disorders
occur regularly in dialysis patients.
Other psychologic symptoms of depression also
defy measurement because of the presence of renal
failure and its attendent psychosocial problems. For
example, exaggerated dependency needs that ac-
company depression could be confused with the ac-
tual increased dependency of the renal patient.
Guilt that accompanies depression could be mistak-
en for other guilt, e.g., guilt over taking an organ
from a recipient [11] or guilt over making new de-
mands on the family. Depressive feelings of weak-
ness or malaise cannot be evaluated, nor can de-
creased mobility, narrowed interests, or reduced at-
tention span, all of which can be nondepressive
accompaniments of the illness or treatment. The
suicidal thoughts our patient had are not uncom-
mon. That does not mean these thoughts should be
dismissed or ignored but that they should be consid-
ered in the context of the total situation.
Depression often occurs secondary to a loss—the
loss of a relationship, a material loss, or even a sym-
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bolic loss such as loss of pride or self-esteem. The
renal patient experiences losses ranging from ne-
phrectomy and the loss of body integrity and func-
tion, to economic and occupational losses, food and
sexual deprivation, disruption of recreational activi-
ties, hospitalization with separation from family and
friends, and the unpredictability of health. Ulti-
mately, the patient realistically fears loss of life.
At times, depression can be manifest by symp-
toms of self-destructive behavior such as neglecting
the dialysis access site, flaunting the diet, or drug
abuse. In a recently published Nephrology Forum,
the patient was admitted to the hospital after omit-
ting her medication because of "emotional stress
and depression" [121.
Finally, increased suicide rates among hemo-
dialysis patients result from the high incidence of
depression in this group. Abram and his associates
collected information from 3478 patients at 201 he-
modialysis centers across the United States [13].
The incidence of suicide was more than 100 times
the rate in the general population; about 5% of dial-
ysis patients ended their lives by suicide.
Medications
I think it would be useful to review some of the
general neuropsychiatric problems concerning the
use of drugs in renal patients before discussing this
patient's specific drug problem. In these patients,
the number of drugs that can cause psychologic or
neuropsychiatric disturbances are legion. Anti-
hypertensive drugs often are implicated in mood or
other disturbances. Drugs that can cause psycho-
logic disorders are used routinely in renal patients,
who might be psychiatrically unstable because of
existing electrolyte and water imbalances, metabol-
ic derangements derived from the renal disease,
concomitant medical disorders, or the primary
treatment itself. Our patient today was noted to be
depressed during therapy with antihypertensive
medication, although the specific drugs were not
named. She was later reported to be depressed
when given steroid therapy following trans-
plantation. The degree to which the drugs were im-
plicated in causing her depression was not men-
tioned. Amitriptyline administered while the patient
was undergoing dialysis led to improvement of her
depression.
The importance of selecting appropriate pharma-
cologic agents leads me to a brief discussion of the
use of psychotropic medication in the patient with
renal failure [14, 15, 16, 171. The phenothiazines are
metabolized by the liver, and only small quantities
of unchanged drug are excreted in the urine. Gener-
ally, only slight dosage modification is required;
however, certain metabolic processes slow down in
uremia, and drugs dependent on enzymatic degra-
dation by the liver can reach toxic levels with nor-
mal dosage. Phenothiazines should not be pre-
scribed prior to dialysis because of the risk of hypo-
tension. The anticholinergic effects of these
compounds should be taken into account in patients
already having difficulty with urination, such as
those suffering from prostatic hypertrophy or
neurogenic bladder.
Diazepam, largely protein-bound, depends on
liver metabolism for degradation to active and in-
active metabolites, which then are excreted in the
kidney. Metabolites can accumulate in patients with
renal insufficiency, so diazepam should be used with
care. Parenteral administration of diazepam in a
patient on hemodialysis can cause hypotension or
respiratory distress.
Lithium is freely filtered across the glomerular
membrane and is reabsorbed with water and sodium
in the proximal tubule. It is also freely dialyzed. In
the manic-depressive patient, the drug should be
administered after dialysis; the dosage and serum
lithium levels should be closely monitored both be-
fore and after dialysis.
Long-acting barbiturates should be avoided in
patients with renal failure because these agents de-
pend on renal function for excretion. Shorter-acting
barbiturates are metabolized in the liver, and only
small amounts of their active and inactive metabo-
lites are excreted in the urine. Phenobarbital, a
weak organic acid, exists in both ionized and un-
ionized form depending on the pH of the tubule
fluid. Raising the urinary pH transforms the drug
into its nondiffusible (and nonreabsorbable) ionic
form and increases its excretion in the urine.
The tricyclic antidepressants are metabolized al-
most entirely in the liver, and only small quantities
of unchanged drug are found in the urine. A major
dosage modification in renal patients, therefore, is
not required. The drugs' cardiotoxic and anti-
cholinergic effects must be kept in mind, however.
Hypotension from these agents can aggravate car-
diac and renal function. Because the antihyperten-
sive effect of guanethidine can be blocked by anti-
depressant medication, initial doses should be small
and gradually increased. In our patient today, the
use of amitriptyline was, at least temporarily, an
effective treatment for depression.
Addiction
Given the high frequency and severity of depres-
sion and physical suffering, as well as the neuropsy-
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chiatric problems due to drugs, the potential for
drug abuse is ever present in renal patients. We
have no explanation of how our patient became ad-
dicted to narcotics. The word abuse was used,
which suggests that there might not have been in-
ordinate pain or other compelling medical in-
dications for the narcotics used. Further, no infor-
mation is available regarding the patient's psychiat-
ric hospitalization or how her addiction was
evaluated and managed. I presume that the patient
complained of pain postoperatively, and that those
complaints led to the original dispensing of Per-
codan® and Percocet®, and subsequently to the
perpetuation of her habit. It obviously would be dif-
ficult to ignore the pleas and demands of this forlorn
young woman who suffered a long series of losses
and disappointments. Her passive suffering manner
would include an inviting although unspoken de-
mand for you to "do something" for her, to relieve
her, to perhaps make up for her deprivations and
deficiencies, and to do for her what the trans-
plantation did not: make her feel better. Would nar-
cotics relieve her? Early in her life this woman ex-
perienced physical abuse from her alcoholic father;
later, she took physical abuse from her medical dis-
order and treatments. She appears similar to the
passive, marginally functioning, orally dependent in-
dividual we often consider predisposed to the devel-
opment of a drug addiction.
Our patient was admitted to the psychiatric unit
because of drug abuse but was not withdrawn from
narcotics. There is no clear explanation of why drug
withdrawal did not take place. It certainly was not
from lack of attention to the carefully counted 1345
Percodan® tablets dispensed over five and one-half
months. Our patient was likely the victim of institu-
tional and situational circumstance. If no medical
indication for narcotics existed, the patient could
have benefited from readmission to the Psychiatry
Service, with a joint treatment plan, a specific drug-
withdrawal schedule, and ongoing liaison between
the nephrologists and the psychiatrists.
Withdrawal from narcotics, however, might not
have been accomplished with impunity: the addic-
tion might have been used by the patient as an at-
tempt to medicate herself for depression. After drug
withdrawal, her depression would still require treat-
ment. If possible, I would have reduced to a mini-
mum her prednisone or other medications that
might have contributed to her psychiatric symp-
toms. Psychotherapy should be instituted to deal
directly with the deprivations described in the his-
tory and with the indignities of her disorder and
treatment. The losses of the social worker and the
dialysis unit staff, which duplicate the losses of her
childhood, also should be explored.
Family relationships
This patient's family history is striking in that it
describes a hostile and dependent relationship with
the mother, the mother's two marriages and di-
vorces (one divorce coincident with the onset of the
nephritis), and a chaotic and unstable home life; yet
there is no mention of the mother's involvement af-
ter the patient became ill. The mother maintained a
low profile in the history, if not in the actual life, of
the patient. The mother's involvement certainly
would profoundly affect the patient. If her mother
had been busy with her own life, maintaining narcis-
sistic investments and ensuring her own survival,
and either subtly or overtly ignoring our patient,
perhaps rejecting, diminishing, or even under-
mining our patient, that would explain a missing
piece of the puzzle. We then could understand the
patient adopting an abandoned and self-destructive,
if not martyred, position when feeling helplessly
thrown to the devices of her disease, treatment, and
caretakers. Neither narcotics nor individual mem-
bers of the dialysis unit staff could make up for this
important maternal deficiency.
The patient's general relationship with her young-
er brother, the kidney donor, also requires atten-
tion. Guilt over taking her brother's kidney and oth-
er psychic complications related to the donor-recip-
ient relationship have to be explored. As we have
seen in other organ recipients, patients can believe
that their gains are at the expense of the donor. Any
organ recipient can feel that the donor incurs a loss
or suffers, and that the recipient lives at the donor's
cost. Both kidney donor and recipient usually are
aware of the donor's sacrifice—the small but real
risk of developing renal insufficiency with a single
kidney—and the recipient is well aware of what it
means to suffer from renal disease.
The issue of indebtedness is important in trans-
plantation psychology. Ralph Waldo Emerson said:
In nature, nothing can be given, all things are
sold," This aptly describes the transplantation
transaction and could apply to our patient, who
thought that a dramatic psychologic as well as phys-
iologic change would occur following trans-
plantation. This notion, which sometimes exists in
an even more elaborate form and occurs commonly
in transplantation patients [111, should be explored
and resolved. Other patients have developed severe
intrapsychic conflicts concerning a kidney donated
from someone of a different age group or the oppo-
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site sex. Some patients believe that the new organ
will transform them sexually or in some other fash-
ion. The post-transplantation reality dispels fantasy
and sometimes leads to severe disappointment or
dejection. For the patient presented, psychotherapy
in combination with antidepressant medication was
indicated and might have proved successful. Ami-
triptyline could have been prescribed again or re-
placed with an equivalent antidepressant agent.
Our patient's history contained a reference to her
engagement, but we have no definitive statement re-
garding the outcome of the relationship. Although
she may have preferred her dependence on her
mother to marriage, other reasons can explain why
relationships of end-stage renal patients become
strained or fail. One of these reasons is sexual dys-
function.
Sexual disorders in the uremic patient
Over one-half of uremic men and over one-third
of uremic women experience severe sexual dis-
orders. Women undergoing hemodialysis report a
marked decrease in frequency of intercourse and
orgasm. In one study of 429 hemodialysis patients,
approximately 60% of the men considered them-
selves partially or totally impotent [18].
Faltering sexual performance that results from
uremia is not helped by dialysis. Even though ure-
mic patients can exhibit improvement in other so-
matic functions, their sexual functioning can deteri-
orate while they are being dialyzed. Kaplan de
Nour reported that male patients' sexual function-
ing deteriorated only after they were established on
maintenance dialysis programs for an extended pe-
riod [19].
A psychogenic cause of sexual dysfunction can-
not be established until physical causes are ruled
out. Renal dialysis patients are uremic and anemic,
and most have hyperparathyroidism. Their access
sites exaggerate circulatory and bleeding problems.
Various hormonal abnormalities have been report-
ed [20, 211. Women have menstrual changes; men
have lowered sperm counts and reduced testicle
size. Some men have reduced testosterone with
normal luteinizing hormone levels; others have nor-
mal testosterone accompanied by elevated lute-
inizing hormone levels. At this time, it is unclear
where along the hypothalamo-pituitary-gonadal
axis the problems exist.
Antoniou et al reported a study of a group of eight
impotent male hemodialysis patients, four treated
with zinc chloride added to their dialysis bath, and
four maintained as controls [221. Three patients re-
ceiving zinc reported a striking improvement in po-
tency after 2 weeks. The fourth treated patient re-
ported some improvement after 4 weeks, but no pa-
tient recovered his predialysis level of sexual
function. There was no change in sexual function in
the control patients. Massry et al treated seven im-
potent male hemodialysis patients with 1 ,25-dihy-
droxycholecalciferol to suppress parathyroid activi-
ty. [231. Four patients reported total recovery of
sexual function, and one reported increased fre-
quency of intercourse. However, to date no impres-
sive statistical studies have been reported.
Aids to the differential diagnosis of psychogenic
versus organic impotence include plethysmographic
studies of vaginal blood flow and temperature
change in women and of nocturnal penile tumes-
cence in men during the rapid eye movement
(REM) phase of sleep [24]. How sexual function
might have affected our patient and her relationship
with her fiancé or with others is not stipulated in the
history, but this information could shed light on her
depression and psychologic state.
If our transplant patient could have been with-
drawn from narcotics and treated for depression,
we then would have had a passive, orally dependent
patient with a kidney transplant who was receiving
prednisone and other drugs, a woman forlorn and
distraught by her pre-existing personality and life
history. Freud proposed that the best we can do is
transform neurotic misery into common unhappi-
ness [25]. Perhaps that is the most that is possible
with this patient.
In conclusion, this patient demonstrates the pro-
found nexus between renal treatment and the psy-
chology of the patient. She draws attention to the
ways treatment can affect depression, family rela-
tions, and sexual function, and points up the risks of
drug abuse and addiction. Finally, she illustrates the
psychiatric implications of the always difficult
choice between hemodialysis and transplantation.
Questions and Answers
DR. J. T. HARRINGTON: We might gain a clearer
understanding of the patient presented today
through a detailed discussion of certain events.
However, a case summary of 3, 10, or even 50
pages could not adequately trace the complex and
difficult course of this patient over the last 2 to 3
years. Perhaps Dr. Bushinsky, who joined me in the
management of this patient, might wish to comment
on her addiction to narcotics, which developed fol-
lowing kidney transplantation.
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DR. DAVID BUSHINSKY (Renal Fellow,
NEMCH): When the patient was discharged from
the hospital, no narcotic drugs were included in her
medications. She did quite well until we began to
decrease her clinic visits. The patient then devel-
oped calf pain and vague knee pain, which she said
prevented her from returning to work. Her symp-
toms were not typical of phlebitis and we did not
want to hospitalize her for a full investigation.
Nonetheless, the pain was chronic and we pre-
scribed pain medication. It soon became obvious
that the patient was abusing the medication; on
three well-documented occasions she obtained ad-
ditional medication by claiming that she had lost the
prescription, when actually she had filled it at an-
other pharmacy.
We made many attempts to persuade the patient
to avail herself of the drug-withdrawal program at
this hospital, but she always found a reason com-
pelling her to delay entering it for 3 or 4 weeks. We
therefore chose to give her the pain medication she
needed rather than risk her discontinuing predni-
sone and azathioprine, thereby endangering her kid-
ney transplant. We documented every pain tablet
she took because we wanted to know the extent of
her addiction.
DR. HARRINGTON: The patient was withdrawn
from Percodan and given methadone, but she has
never been able to discontinue the methadone. She
still travels approximately 150 miles daily to an out-
patient methadone clinic. We were very concerned
that if we broke our relationship with her by not
giving her pain medication, she might have stopped
taking the medications necessary to maintain the
transplanted kidney. That actually occurred several
years ago when a patient of mine discontinued tak-
ing all medications and allowed a well-functioning
kidney to be rejected so that she could return to the
protective environment of the hemodialysis unit.
DR. S. BASCH: Apparently, this patient is a ma-
nipulative person. One can sense considerable dis-
comfort among the medical staff because she influ-
enced the therapeutic decisions. The term tyranny
by the mentally ill" describes this uncomfortable
situation, which is comparable to a child who
threatens a temper tantrum if refused something by
the parents. A possible approach to this patient's
problem would be to hospitalize her for drug with-
drawal and concentrated psychotherapy while over
an extended period of time attempting to define with
her the source and extent of her need for narcotics.
Like your other patient, she might find the environ-
ment of the dialysis unit preferable to working and
functioning in the outside world; this is a typical re-
sponse in patients with passive/dependent personal-
ities. In any event, a very large commitment on the
part of the Psychiatry Service would be required.
DR. JOYCE ROOT (Liaison Psychiatrist to the
Renal Service): I should like to comment on the pa-
tient's admission to the psychiatric inpatient unit
for treatment of depression and narcotic with-
drawal. Before she was admitted, I had arranged
with the residents that she be detoxified. Unfortu-
nately, her admission coincided with the July
change of house staff and she was able to convince
the new house staff to continue giving her medica-
tion. She then had no further interest in investigat-
ing her depression and she ultimately left the in-
patient unit extremely angry and still drug depen-
dent. Ideally, she should have been admitted to a
psychiatric unit equipped to provide extended in-
patient milieu and individual psychotherapy fo-
cused on her underlying depression.
DR. J. J. COHEN: Several general issues are
raised by our experience with this patient. You
mentioned the difficulty of assessing depression
during the course of dialysis because depressive
symptoms so easily can be ascribed to other medi-
cal concerns. Are there valid psychologic tests that
can be used for discriminating between 'endoge-
nous" depression and the depression that might
stem simply from the dialysis experience itself'?
DR. BASCH: Yes, psychologic tests can be helpful
in obtaining a more objective evaluation of the pa-
tient's mental status. An additional important factor
in assessing the depression is its degree. Complete
withdrawal from family and friends certainly is
more significant than are low spirits. If the patient
manifests symptoms of psychotic depression such
as delusions, the problem is more likely pathologic
than reactive. Many patients experience reactive
depression during the first 6 months of dialysis ther-
apy. It is so common that medical teams take it for
granted. If the depression continues beyond the 6-
month period, however, or if it lasts longer than 2
months, more attention should be paid to that as-
pect of the patient's well being.
DR. COHEN: Are different therapeutic strategies
indicated for pathologic depression as compared to
reactive depression?
DR. BASCH: Yes. Because the patient is an indi-
vidual, the therapeutic approach varies. Psycho-
therapy should be employed whenever feasible.
Some patients, however, can be treated more ef-
fectively with antidepressive agents. We have
treated manic-depressive patients with lithium, al-
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though this has been difficult. We have even used
electroconvulsive therapy (ECT) on occasion, espe-
cially in patients whose cardiac function is com-
promised and in whom the cardiotoxic tricyclic
drugs are contraindicated. Electroconvulsive thera-
py might be necessary in suicidal patients or in pa-
tients whose clinical conditions are life threatening
because they have stopped eating or taking care of
themselves. Immediate intervention is necessary in
this situation, and the tricyclic agents may not
achieve effective levels for at least 2 weeks.
DR. JAMES STROM (Renal Fellow, NEMCH): Are
tricyclic drugs ever indicated in dialysis patients
who have a simple mood disorder?
DR. BASCH: Again, I think that patients should be
evaluated individually. Some people remarkably
adapt to dialysis with no depression at all. Some
patients are able to use denial and other kinds of
defenses to make the adjustment. When treatment
is necessary. I hold that psychotherapy is prefer-
able to the use of drugs. When psychotherapy fails,
I think tricyclic agents can be used selectively, but
not indiscriminately in the renal patient undergoing
dialysis.
DR. HARRINGTON: I would like to return to one of
the questions that arose earlier: the use of psycho-
logic tests. One of the problems we encounter in
patients like this is predicting the effectiveness of
nursing, medical, and psychiatric care. What specif-
ic kinds of preoperative psychologic evaluation and
screening should be performed to avoid the prob-
lems we had in this patient?
DR. BASCH: That is a very difficult question.
Even with psychologic screening we might end up
transplanting some problem patients. Further, you
would not want to have excessively strict criteria.
There are certain people who are going to be self-
destructive. They either might be suicidal or self-
destructive in other ways. A great deal of informa-
tion can be gained from clinical observation. You
may know from the clinical history without doing
psychologic testing that these patients will under-
mine their own treatment and that their transplants
will not last. Their behavior on dialysis is a partial
model for their sense of responsibility in taking care
of themselves. One also can undertake formal psy-
chologic examination, although we do not do this
routinely. We have found that a striking number of
patients have previously undetected low-grade or-
ganic brain disease [261. I believe that it is more
practical simply to rely on interviewing and close
observation of the patient during the dialysis experi-
ence.
DR. COHEN: In treating patients with end-stage
renal disease, one cannot help but be struck by how
frequently serious psychiatric disease crops up. It
almost seems that nature selects out psychological-
ly weaker individuals to afflict with kidney disease.
Obviously, this is not true. I think we would all
agree that the stresses of this disease and its treat-
ment allow for the expression of certain psycholog-
ic weaknesses that would have remained dormant
under ordinary circumstances. That being the case,
psychiatric disease should be no more common in
this group of patients than in other equally stressed
groups. Are any data available to substantiate this
view?
DR. BASCH: I have never seen such data. How-
ever, I will share my thoughts about it with you.
Physicians treating individuals with end-stage renal
disease get a lot closer to their patients and discover
psychologic facts that would not become apparent
in the ordinary intercourse of life. Further, special
factors operate here that bring out and exaggerate
conflicts and problems. The first is that a chronic
severe illness is invariably regressive. Regression
does bring out neurosis, the essence of which is de-
rived from childhood. Second, these people who
are uremic have altered mental states and tenuous
mental faculties. There is a strong interplay, if not
synergism, between their neurologic and psycho-
logic cerebral function. Thus tendencies toward
psychiatric illnesses might become manifest in an
exaggerated way because of this interplay.
DR. ROOT: I wonder whether you might comment
about the problem of body image in this population
of patients and how it relates to having an illness
that can be cured by taking a body part from some-
one else.
DR. BASCH: The treatment of end-stage renal dis-
ease is a circumstance in which the body is intruded
on in very special ways [1, 11, 26, 27]. The idea of
extracorporeal circulation is remarkable; some pa-
tients describe it as "watching their body go by" as
the blood circulates to and from the machine. Dis-
tortions of the body image stem from being sub-
jected to a myriad of procedures, including access-
site procedures, peritoneal dialysis, and nephrecto-
my. Freud said the ego is essentially a body ego.
Our bodies dictate our sense of ourselves. How
people experience life physically is very important
in terms of the way they think about themselves.
Renal patients have suffered so much mentally and
physically that they perceive themselves as damaged,
distorted, and at times worthless. This is reflected
in a dream that was reported to me by a patient who
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did not associate or interpret it. The patient is a
black man in his forties who had worked as a packer
in the garment industry. He reported "I had this
dream and I couldn't tell where it took place. It was
either in the dialysis unit or in the factory where I
used to work in the garment industry. There were
stacks of things around and I wasn't sure if it was
dialysis equipment or fabric. There were people
lined up and I wasn't sure if they were there to work
in the fabric place or they were waiting for dialysis.
There were people at the other end of the line in
white coats but I couldn't tell what they were. They
might have been doctors or nurses but they might
have been the packers. I was in line with these
people. Finally I decided that it was a dialysis unit
and since I was a dialysis patient I felt relieved. But
when we got up to the front of the line they packed
the people inside of the boxes and tied the outside
with dialysis tubing." He awakened at this point.
Although there were no associations to the dream,
it speaks for itself about the patient's sense of his
body and himself, a notion shared by other dialysis
patients, and perhaps by the patient presented
today.
Reprint requests to Dr. Samuel H. Basch, Department of Psy-
chiatry, Mount Sinai School of Medicine, 100th Street and Fifth
Avenue, New York. New York 10029.
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